Anush Shares and Securities

CLOSE X
Equity 
YOU ARE ON : Home | Equity | Comapny Profile | Summary
Summary
Biocon Ltd.
BSE CODE: 532523   |   ISIN CODE : INE376G01013
BSE
617.35
10.5 ( 1.73% )
 
Prev Close ( Rs.)
606.85
Open ( Rs.)
607.05
 
High ( Rs.)
617.60
Low ( Rs.)
605.90
 
Volume
30878
Week Avg.Volume
59905
 
52 WK High-Low Range
BSE NSE
616.20
10.35 ( 1.71% )
 
Prev Close ( Rs.)
605.85
Open ( Rs.)
608.40
 
High ( Rs.)
616.60
Low ( Rs.)
605.20
 
Volume
599421
Week Avg.Volume
1177380
 
52 WK High-Low Range
543.3
718
1D   | 1M   | 3M   | 1Y  | 3Y  | 5Y
You need to upgrade your Flash Player
Competitors
Company NameLast Price (Rs.)Chg (Rs./%)Sales TurnOverVolume
Sanofi India6012.0039.35(0.66)869.9125.00
Abbott India7307.4029.55(0.41)796.6215.00
Jenburkt Pharma487.7527.95(6.08)133.4820.00
Themis Medicare301.9521.45(7.65)169.362234.00
Fredun Pharma350.0020.10(6.09)64.64621.00
More>
KEY PERSONNEL & ADDRESS
Chairman
Kiran Mazumdar-Shaw
Managing Director
Kiran Mazumdar-Shaw
Company Secretary
Satish Kumar SS
Promoter & Non-Executive Director
John Shaw
Ravi Mazumdar
Joint Managing Director
Arun Chandavarkar
Independent Director
Bobby Kanubhai Parikh
Registered Office :
20th Km,Hosur Road,Electronic City, Bengaluru,
Karnataka-560100 .
Phone :
91-80-2808-2808  
E-mail :
investor.relations@biocon.com / co.secretary@biocon.com
URL
www.biocon.com
 
News On BIOCON
18/02/2019
USFDA concludes two pre approv...
18/02/2019
Biocon informs about disclosur...
25/01/2019
Biocon reports over 2-fold jum...
25/01/2019
Biocon falls despite reporting...
More >
Financials
QUARTERLY (Dec 18)
Net Profit( Rs . In Cr) 727
Gross Profit( Rs . In Cr) 820
Operating Profit( Rs . In Cr) 1205
Net Sales( Rs .In Cr) 7397
More>
MF Holding Details
Scheme NameMkt value (In Cr.)
Aditya Birla SL Tax ...186.76
Reliance Pharma Fund...151.22
ICICI Pru Bluechip F...149.87
Aditya Birla SL Equi...97.31
ICICI Pru Pharma Hea...84.17
SBI Healthcare Opp F...50.32
Reliance Growth Fund...40.89
More>
Attention Investors: "Prevent Unauthorized Transactions in your account --> Update your Mobile Numbers/email IDs with your stock brokers. Receive information of your transactions directly from exchange on your mobile/email at the end of the day..... issued in the interest of investors. "
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account
Prevent Unauthorized Transactions in your demat account:Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from Exchange / CDSL on the same day.........issued in the interest of investors.
SEBI REGN NO: NSE~ INB/F/E 231445330 | BSE~INB/F 231445330 | MSE- INB040817131 | DP~IN-DP-CDSL-683-2013 | Member ID : NSE :14453 | BSE: 6281 |MSE: 08171| MCX-SX: 11280 |SCM F&O: M50171 | AMFI: 2110

NSE
×